Herbas VPB

Print
EN | LT
LT - ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS
EN - ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/55
A61K 31/00
A61P 25/28
A61K 9/00
A61K 9/107
A61K 9/14
A61K 9/20
A61K 9/28
European patent
(11) Number of the document 2877165
(13) Kind of document T
(96) European patent application number 13745810.5
Date of filing the European patent application 2013-07-29
(97) Date of publication of the European application 2015-06-03
(45) Date of publication and mention of the grant of the patent 2018-09-05
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2013/065880
Date 2013-07-29
PCT application publication
(87) Number WO 2014/016430
Date 2014-01-30
Priority applications
(30) Number Date Country code
201261676348 P 2012-07-27 US
12178187 2012-07-27 EP
Inventors
(72)
MAELICKE, Alfred, DE
Grantee
(73) Neurodyn Life Sciences Inc., Suite 508 NRC-INH 550 University Ave.,, Charlottetown, P.E.I., C1A 4P3, CA
Title
(54) ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS
  ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS
Last update date 2021-04-30